Form 4: Natera Co-Founder Jonathan Sheena Reports Stock Transactions
SEC Form 4 Filing
Jonathan Sheena, co-founder of Natera, Inc., reports transactions involving common stock and restricted stock units, including sales to cover tax obligations.
Summary
- On April 20, 2025, Jonathan Sheena exercised 190 Restricted Stock Units (RSUs) which converted into common stock.
- On April 21, 2025, Sheena sold 85 shares of common stock at $145.54 and 1 share at $146.16.
- These sales were to cover tax withholding obligations related to the vesting of RSUs, and were executed under a pre-arranged 10b5-1(c) trading plan.
- Following these transactions, Sheena directly owns 255,353 shares of Natera common stock.
- Sheena also indirectly owns 40,282 shares through the Caraluna 1 Trust and 40,282 shares through the Caraluna 2 Trust, but disclaims beneficial ownership of these shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports stock transactions related to RSU vesting and tax obligations, which is a routine occurrence.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential sentiment.
Comparison to Industry Standards
- Form 4 filings are a standard regulatory requirement for corporate insiders in publicly traded companies, ensuring transparency in their trading activities.
- Similar filings are common across the biotechnology and diagnostics industries, with companies like Exact Sciences and Guardant Health also regularly reporting insider transactions.
- The use of 10b5-1 trading plans is a common practice among executives to avoid accusations of insider trading, aligning with industry best practices for compliance.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the small number of shares sold.
- Employees holding RSUs may be interested in the vesting schedule and tax implications.
Key Dates
| Date | Description |
|---|---|
| 01/28/2022 | Date of Reporting Person's Stock Unit Agreement |
| 01/20/2023 | 25% of RSUs vested |
| 04/20/2025 | Exercise of 190 Restricted Stock Units |
| 04/21/2025 | Sale of Natera common stock |
| 04/22/2025 | Date of Form 4 signature |
Keywords
Natera, NTRA, Jonathan Sheena, Form 4, Stock Transactions, Restricted Stock Units, RSU, Beneficial Ownership, Insider Trading, 10b5-1(c) plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.